These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 39241387)

  • 1. Demethylzeylasteral ameliorates podocyte damage in murine lupus by inhibiting inflammation and enhancing autophagy.
    Shen P; Deng X; Chen Z; Chen M; Han L; Chen X; Tu S
    Phytomedicine; 2024 Nov; 134():155966. PubMed ID: 39241387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
    Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy.
    Zhao XY; Li SS; He YX; Yan LJ; Lv F; Liang QM; Gan YH; Han LP; Xu HD; Li YC; Qi YY
    Ann Rheum Dis; 2023 Oct; 82(10):1328-1340. PubMed ID: 37487609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-κB and MAPK signalling pathways in MRL/lpr mice.
    Li X; Liu J; Zhao Y; Xu N; Lv E; Ci C; Li X
    BMC Nephrol; 2022 Jul; 23(1):243. PubMed ID: 35804318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin improves renal injury of MRL/lpr lupus-prone mice via the AMPK/STAT3 pathway.
    Chen XC; Wu D; Wu HL; Li HY; Yang C; Su HY; Liu ZJ; Huang XR; Lu X; Huang LF; Zhu SP; Pan QJ; An N; Liu HF
    Lupus Sci Med; 2022 Apr; 9(1):. PubMed ID: 35414608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demethylzeylasteral (T-96) Treatment Ameliorates Mice Lupus Nephritis Accompanied by Inhibiting Activation of NF-κB Pathway.
    Hu Q; Yang C; Wang Q; Zeng H; Qin W
    PLoS One; 2015; 10(7):e0133724. PubMed ID: 26208003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement factor B inhibitor LNP023 improves lupus nephritis in MRL/lpr mice.
    Chen K; Deng Y; Shang S; Tang L; Li Q; Bai X; Chen X
    Biomed Pharmacother; 2022 Sep; 153():113433. PubMed ID: 36076550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procyanidin B2 prevents lupus nephritis development in mice by inhibiting NLRP3 inflammasome activation.
    He J; Sun M; Tian S
    Innate Immun; 2018 Jul; 24(5):307-315. PubMed ID: 29874961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pim-1 as a Therapeutic Target in Lupus Nephritis.
    Fu R; Xia Y; Li M; Mao R; Guo C; Zhou M; Tan H; Liu M; Wang S; Yang N; Zhao J
    Arthritis Rheumatol; 2019 Aug; 71(8):1308-1318. PubMed ID: 30791224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling the podocyte injury in lupus nephritis: Clinical and experimental approaches.
    Dos Santos M; Poletti PT; Milhoransa P; Monticielo OA; Veronese FV
    Semin Arthritis Rheum; 2017 Apr; 46(5):632-641. PubMed ID: 27839739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective capability of
    Li Y; Ding T; Chen J; Ji J; Wang W; Ding B; Ge W; Fan Y; Xu L
    Front Immunol; 2022; 13():943827. PubMed ID: 35958622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sophocarpine attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation.
    Li X; Wang M; Hong H; Luo C; Liu Z; Yang R
    Immunol Res; 2018 Aug; 66(4):521-527. PubMed ID: 30047025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice.
    Hu L; Hu J; Chen L; Zhang Y; Wang Q; Yang X
    Front Immunol; 2021; 12():584414. PubMed ID: 33717066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocytes and autophagy: a potential therapeutic target in lupus nephritis.
    Zhou XJ; Klionsky DJ; Zhang H
    Autophagy; 2019 May; 15(5):908-912. PubMed ID: 30755075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-like 4 (ANGPTL4) Suppression Ameliorates Lupus Nephritis in MRL/lpr Mice by Inactivating NLRP3 Inflammasome and Inhibiting Inflammatory Response.
    Luo D; Li J; Hu M; Wang Y; Pi P; Ning M; Wu J
    Iran J Immunol; 2023 Sep; 20(3):316-326. PubMed ID: 37543838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-prolactin treatment alleviates lupus conditions by regulating the JAK2-STAT3 pathway.
    Jiang Y; Chen H; Lin J; Pan J; Shen Y; Li Q
    Clin Exp Pharmacol Physiol; 2023 Dec; 50(12):936-943. PubMed ID: 37727880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased autophagy is cytoprotective against podocyte injury induced by antibody and interferon-α in lupus nephritis.
    Qi YY; Zhou XJ; Cheng FJ; Hou P; Ren YL; Wang SX; Zhao MH; Yang L; Martinez J; Zhang H
    Ann Rheum Dis; 2018 Dec; 77(12):1799-1809. PubMed ID: 30209031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursolic acid alleviates lupus nephritis by suppressing SUMO1-mediated stabilization of NLRP3.
    Chen L; Li F; Ni JH; Hao YX; Feng G; Shen XY; You Y
    Phytomedicine; 2024 Jul; 130():155556. PubMed ID: 38810552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-25 is upregulated in patients with systemic lupus erythematosus and ameliorates murine lupus by inhibiting inflammatory cytokine production.
    Li Y; Wang R; Liu S; Liu J; Pan W; Li F; Li J; Meng D
    Int Immunopharmacol; 2019 Sep; 74():105680. PubMed ID: 31200339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baricitinib Attenuates Autoimmune Phenotype and Podocyte Injury in a Murine Model of Systemic Lupus Erythematosus.
    Lee J; Park Y; Jang SG; Hong SM; Song YS; Kim MJ; Baek S; Park SH; Kwok SK
    Front Immunol; 2021; 12():704526. PubMed ID: 34497607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.